This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
miLab Platform ProductsImprove diagnostic workflows
Improve diagnostic workflows
and accessibility at once
CLINICAL EVIDENCE
Explore the Clinical Evidence Behind NOUL Innovation
Explore Clinical Evidence Beyond DiagnosticsWe provide products and services that impact
We provide products and services that impact
one billion people's lives in the world.
Noul focuses on the most challenging healthcare issues the world has yet to resolve.
We deliver innovative diagnostic solutions in blood and tissue diagnostics to dramatically improve medical access and
conquer cancer.
Our Story in Numbers
- NVIDIA GTC selected AI Startups
- Top 0
- Cumulative investment (USD)
- 0million
- Annual sales growth (as of 2023)
- 0%
We continue to grow, moving toward the next stage.
- Patent registrations and applications
- 0cases, 0cases
- Cumulative orders for National R&D project (USD)
- 0million
- Researcher in company
- 0%
We create innovation based on R&D and technology patents.
- Countries using miLab™
- 0countries
- Cumulative diagnosis using miLab™
- 0diagnoses
- Partner organizations
- 0+
miLab™ Solution leads the global blood and cancer diagnosis.
- Digitalize entire process (stain, scan, AI analyze)
- All inOne
- Time required for diagnosis (more than 2x improvement)
- Avg0mins
- Accuracy of test results (Labcorp clinical trial - miLab™ MAL)
- Sensitivity0% ,
Specificity0%
miLab™ Solution has dramatically improved the diagnostic process.
Noul Highlights
Find our latest news
View More-
Noul Sustainability Report 2025-2026 Noul Co., Ltd. has published its sixth Sustainability Report. In accordance with its Articles of Incorporation, Noul has published a Sustainability Report every year since 2020 to periodically report its economic, social, and environmental activities and achievements to stakeholders. The 2025-2026 Sustainability Report summarizes Noul’s key management activities… Read MoreNews | 2026.07.10
-
Beyond Counting: How AI Is Closing the Gap with Expert Blood Cell Morphology Source: DKMS Every year on May 28, the world observes World Blood Cancer Day –… Read MoreBlog | 2026.05.22
-
Now We Can. Now We Must. — World Malaria Day 2026 Table of Contents Toggle The Global Malaria LandscapeWhy… Read MoreBlog | 2026.04.24
-
Noul’s International Women’s Day Table of Contents Toggle Why International Women’s Day Was Established… Read MoreBlog | 2026.03.26
-
Laboratory Diagnostics Insights from WHX Labs Dubai 2026 Table of Contents Toggle WHX Labs Dubai 2026: A Platform for Laboratory Innovation… Read MoreBlog | 2026.02.25
-
From Compliance to Global Scale: Preparing AI Diagnostics for MDSAP and IVDR Table of Contents Toggle MDSAP and IVDR: Shifting Regulatory Expectations for Global… Read MoreBlog | 2026.01.22
- Career Join our team, committed to
making a positive impact - View More
- Sustainability at Noul Sustainability is
at the core of our business philosophy. - Sustainability
